Rosvall, M., G. Engstrom, G. Berglund, and B. Hedblad. 2008. C-reactive protein, established risk factors and social inequalities in cardiovascular disease—the significance of absolute versus relative measures of disease. BMC Public Health 8(189):1-10.
Rothberg, M. B., I. Abraham, P. K. Lindenauer, and D. N. Rose. 2005. Improving nurse-to-patient staffing ratios as a cost-effective safety intervention. Medical Care 43(8):785-791.
Russell, L. B., J. E. Siegel, N. Daniels, M. R. Gold, B. R. Luce, and J. S. Mandelblatt. 1996. Cost-effectiveness analysis as a guide to resource allocation in health: Roles and limitations. In Cost-effectiveness in health and medicine, edited by J. E. Siegel, L. B. Russell, and M. C. Weinstein. New York: Oxford University Press. Pp. 3-24.
Sabik, L. M., and R. K. Lie. 2008. Principles versus procedures in making health care coverage decisions: Addressing inevitable conflicts. Theoretical Medicine & Bioethics 29(2):73-85.
Sarvela, P. D., and R. J. McDermott. 1993. Health education evaluation and measurement: A practitioner’s perspective. Dubuque, IA: William C. Brown Communications, Inc.
Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020. 2008a. Phase I report: Recommendations for the framework and format of Healthy People 2020. Appendix 7. Washington, DC: U.S. Department of Health and Human Services.
———. 2008b. Phase I report: Recommendations for the framework and format of Healthy People 2020. Appendix 14. Washington, DC: U.S. Department of Health and Human Services.
Siegel, B., D. Bear, E. Andres, and H. Mead. 2009. Measuring equity: An index of health care disparities. Quality Management in Health Care 18(2):84-90.
Siu, A. L., E. A. McGlynn, H. Morgenstern, M. H. Beers, D. M. Carlisle, E. B. Keeler, J. Beloff, K. Curtin, J. Leaning, B. C. Perry, H. P. Selker, W. Weiswasser, A. Wiesenthal, and R. H. Brook. 1992. Choosing quality of care measures based on the expected impact of improved care on health. Health Services Research 27(5):619-650.
Stinnett, A. A., and J. Mullahy. 1998. Net health benefits: A new framework for the analysis of uncertainty in cost-effectiveness analysis. Medical Decision Making 18(2):S68-S80.
Stolk, E. A., S. J. Pickee, A. H. J. A. Ament, and J. J. V. Busschbach. 2005. Equity in health care prioritisation: An empirical inquiry into social value. Health Policy 74(3):343-355.
Tengs, T. O., and J. D. Graham. 1996. The opportunity cost of haphazard social investments in life-saving. In Risks, costs, and lives saved: Getting better results from regulation, edited by R. W. Hahn. New York: Oxford University Press. Pp. 167-182.
van Hulst, M., J. T. M. de Wolf, U. Staginnus, E. J. Ruitenberg, and M. J. Postma. 2002. Pharmaco-economics of blood transfusion safety: Review of the available evidence. Vox Sanguinis 83(2):146-155.
Waidmann, T. 2009. Estimating the cost of racial and ethnic health disparities. Washington, DC: The Urban Institute.
Whitehead, M., and G. Dahlgren. 1991. What can be done about inequalities in health? Lancet 338(8774):1059-1063.
Whitlock, E. P., S. A. Lopez, S. Chang, M. Helfand, M. Eder, and N. Floyd. 2010. AHRQ series paper 3: Identifying, selecting, and refining topics for comparative effectiveness systematic reviews: AHRQ and the effective health-care program. Journal of Clinical Epidemiology 63(5):491-501.
Wong, J. B., C. Mulrow, and H. C. Sox. 2009. Health policy and cost-effectiveness analysis: Yes we can. Yes we must. Annals of Internal Medicine 150(4):274-275.
Woolf, S. H. 2009. A closer look at the economic argument for disease prevention. Journal of the American Medical Association 301(5): 536-538.